OnTheIssuesLogo

Martha McSally on Drugs

 

 


No legalization of medical or recreational cannabis

Q: Marijuana: Legalize or decriminalize marijuana?

Martha McSally (R): No. Voted against letting states legalize medical or recreational cannabis. Would allow prescriptions for veterans.

Kyrsten Sinema (D): State option. Voted to let states legalize medical or recreational cannabis.

Source: 2018 CampusElect.org Issue Guide on Arizona Senate race , Oct 9, 2018

Authored bill increasing penalties for drug spotters

McSally introduced a bill to increase penalties for drug spotters operating along our border. I've seen where these spotters operate from and heard frustrations from ranchers and Border Patrol about the lack of consequences and penalties spotters face. Stricter penalties will prevent experienced spotters who are caught from quickly returning to action and deter many others from joining a criminal cartel operation, degrading their ability to circumvent our border controls."
Source: 2018 Arizona Senate campaign website mcsally.house.gov , Mar 24, 2015

Rated C by NORML, indicating a mixed record on drug reform.

McSally scores C by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Other candidates on Drugs: Martha McSally on other issues:
AZ Gubernatorial:
David Garcia
Doug Ducey
Frank Riggs
Fred DuVal
Jan Brewer
JL Mealer
Phil Gordon
Steve Farley
AZ Senatorial:
Ann Kirkpatrick
Deedra Abboud
Doug Marks
Jeff Flake
JL Mealer
Joe Arpaio
John McCain
Kelli Ward
Kyrsten Sinema
Mark Kelly

AZ politicians
AZ Archives
Senate races 2019-20:
AK: Sullivan(R,incumbent) vs.Gross(I) vs.Blatchford(D)
AL: Jones(D,incumbent) vs.Tuberville(R) vs.Sessions(R) vs.Moore(R) vs.Rogers(D) vs.Merrill(R)
AR: Cotton(R,incumbent) vs.Harrington(L) vs.Whitfield(I) vs.Mahony(D)
AZ: McSally(R,incumbent) vs.Kelly(D)
CO: Gardner(R,incumbent) vs.Hickenlooper(D) vs.Madden(D) vs.Baer(D) vs.Walsh(D) vs.Johnston(D) vs.Romanoff(D) vs.Burnes(D) vs.Williams(D)
DE: Coons(D,incumbent) vs.Scarane(D) vs.Witzke(R) vs.DeMartino(R)
GA-2: Isakson(R,resigned) Loeffler(R,appointed) vs.Warnock(D) vs.Collins(R) vs.Tarver(D) vs.Carter(D) vs.Lieberman(D) vs.Grayson(R) vs.Stovall(I) vs.Buckley(L)
GA-6: Perdue(R,incumbent) vs.Ossoff(D) vs.Hazel(L) vs.Tomlinson(D) vs.Terry(D)
IA: Ernst(R,incumbent) vs.Greenfield(D) vs.Graham(D) vs.Mauro(D) vs.Franken(D)
ID: Risch(R,incumbent) vs.Jordan(D) vs.Harris(D)
IL: Durbin(D,incumbent) vs.Curran(R) vs.Stava-Murray(D)
KS: Roberts(R,retiring) vs.Marshall(R) vs.Bollier(D) vs.LaTurner(R) vs.Wagle(R) vs.Kobach(R) vs.Lindstrom(R) vs.Grissom(D)
KY: McConnell(R,incumbent) vs.McGrath(D) vs.Morgan(R) vs.Cox(D) vs.Tobin(D) vs.Booker(D)
LA: Cassidy(R,incumbent) vs.Perkins(D) vs.Pierce(D)

MA: Markey(D,incumbent) vs.O`Connor(R) vs.Ayyadurai(R) vs.Kennedy(D) vs.Liss-Riordan(D)
ME: Collins(R,incumbent) vs.Gideon(D) vs.Sweet(D) vs.Rice(D)
MI: Peters(D,incumbent) vs.James(R) vs.Squier(G)
MN: Smith(D,incumbent) vs.Lewis(R) vs.Overby(G) vs.Carlson(D)
MS: Hyde-Smith(R,incumbent) vs.Espy(D) vs.Bohren(D)
MT: Daines(R,incumbent) vs.Bullock(D) vs.Collins(D) vs.Driscoll(R) vs.Mues(D) vs.Geise(L)
NC: Tillis(R,incumbent) vs.Cunningham(D) vs.E.Smith(D) vs.S.Smith(R) vs.Tucker(R) vs.Mansfield(D)
NE: Sasse(R,incumbent) vs.Janicek(R)
NH: Shaheen(D,incumbent) vs.Messner(R) vs.Martin(D) vs.Bolduc(R) vs.O'Brien(R)
NJ: Booker(D,incumbent) vs.Mehta(R) vs.Singh(R) vs.Meissner(R)
NM: Udall(D,retiring) vs.Lujan(D) vs.Ronchetti(R) vs.Walsh(L) vs.Clarkson(R) vs.Oliver(D) vs.Rich(R)
OK: Inhofe(R,incumbent) vs.Broyles(D) vs.Workman(D)
OR: Merkley(D,incumbent) vs.Perkins(R) vs.Romero(R)
RI: Reed(D,incumbent) vs.Waters(R)
SC: Graham(R,incumbent) vs.Harrison(D) vs.Tinubu(D)
SD: Rounds(R,incumbent) vs.Ahlers(D) vs.Borglum(R)
TN: Alexander(R,retiring) vs.Hagerty(R) vs.Bradshaw(D) vs.Sethi(R) vs.Mackler(D) vs.Crim(R)
TX: Cornyn(R,incumbent) vs.Hegar(D) vs.Hernandez(D) vs.Bell(D) vs.Ramirez(D) vs.West(D)
VA: Warner(D,incumbent) vs.Taylor(R) vs.Gade(R)
WV: Capito(R,incumbent) vs.Swearengin(D) vs.Ojeda(D)
WY: Enzi(R,retiring) vs.Lummis(R) vs.Ben-David(D) vs.Ludwig(D)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings
 





Page last updated: Nov 28, 2020